The Asia Pacific extra corporeal membrane oxygenation (ECMO) system market is projected to register a CAGR of 5.07% during the forecast period, 2019-2028. The rising prevalence of cardiopulmonary diseases is the dominant factor responsible for market growth. Vietnam, Japan, South Korea, India, Japan, Indonesia, China, Australia & New Zealand, and the rest of Asia Pacific, are analyzed for the evaluation of the Asia Pacific extra corporeal membrane oxygenation (ECMO) system market growth. China is considered as one of the major regions in the Asia Pacific for the ECMO market.

ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET FORECAST 2019-2028

Asia Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Market by Modality (Veno-venous, Veno-arterial, Other Modalities) by Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (Ecpr)) and by Geography.

Request free sample

Report Summary

To know more about this report, request a free sample copy

Vietnam, Japan, South Korea, India, Japan, Indonesia, China, Australia & New Zealand, and the rest of Asia Pacific, are analyzed for the evaluation of the Asia Pacific extra corporeal membrane oxygenation (ECMO) system market growth. China is considered as one of the major regions in the Asia Pacific for the ECMO market. The growing healthcare expenditure and the rising patient population are the primary drivers of market growth. Recent studies suggest that the country has a significant number of cardiac and respiratory disorder patients. The increasing awareness, along with the growing number of asthma and COPD cases, is projected to result in market growth opportunities. As per a study, there was a rise in ECMO cases that of 38.8%, an increase of 11.6% from 2017. In the last five years, ECMO has exhibited rapid developments, and many centers have been established. It is also found to have significantly enhanced the prognosis of neonatal and pediatric patients with respiratory and cardiac failure. These factors are estimated to influence market growth. ECMO is considered as a treatment option for ARDS (acute respiratory distress syndrome) in Thailand. Lung cancer is the third-most-common disorder in the country, as per an article. More than 17000 deaths in 2017 were caused by asthma and COPD. Such aspects are set to contribute to market growth.

Microport Scientific Corporation manufactures, develops, and commercializes interventional medical devices across the world. It operates through three segments, cardiovascular, thopedics, and others. The cardiovascular segment supplies products and services for treating coronary artery related diseases. The product portfolio of the company includes the KW membrane oxygenator. The company has its headquarters in Shanghai, China.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
MARKET DYNAMICS
- MARKET DEFINITION
- KEY DRIVERS
  - INCREASED USAGE OF ECMO TECHNOLOGY
  - TECHNOLOGICAL ADVANCEMENT
  - GROWING BURDEN OF CHRONIC DISORDERS
- KEY RESTRAINTS
  - LACK OF SPECIALIZED EXPERTISE
  - HIGH COST OF ECMO SYSTEM
  - SIDE EFFECTS RELATED TO THE ECMO SYSTEM
  - PRESENCE OF CONVENTIONAL TECHNIQUES

KEY ANALYTICS
- PORTER’S FIVE FORCE ANALYSIS
  - THREAT OF NEW ENTRY
  - THREAT OF SUBSTITUTION
  - BUYER’S POWER
  - SUPPLIER’S POWER
  - COMPETITIVE RIVALRY
- IMPACT OF COVID-19 ON ECMO SYSTEM MARKET
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- KEY INVESTMENT INSIGHTS
MARKET BY MODALITY
- VENO-VENOUS
- VENO-ARTERIAL
- OTHER MODALITIES
MARKET BY APPLICATION
- RESPIRATORY
- CARDIAC
- EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
  - CHINA
  - JAPAN
  - INDIA
  - AUSTRALIA & NEW ZEALAND
  - SOUTH KOREA
  - THAILAND
  - INDONESIA
  - VIETNAM
  - REST OF ASIA PACIFIC

COMPANY PROFILES
- ABBOTT LABORATORIES
- ALUNG TECHNOLOGIES INC
- ELSIUS BIOMEDICAL INC
- EUROSETS
- GETINGE AB
- LIVANOVA PLC
- MEDTRONIC PLC
- MICROPORT SCIENTIFIC CORPORATION
- NIPRO CORPORATION
- ORIGEN BIOMEDICAL INC
- SPECTRUM MEDICAL
- TERUMO MEDICAL CORPORATION
- XENIOS AG (FRESENIUS SE & CO KGAA)

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM

TABLE 2: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 4: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 6: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: LIST OF CHRONIC DISEASES

FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: KEY INVESTMENT INSIGHTS

FIGURE 6: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY MODALITY, IN 2019

FIGURE 7: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-VENOUS, 2019-2028 (IN $ MILLION)

FIGURE 8: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY VENO-ARTERIAL, 2019-2028 (IN $ MILLION)

FIGURE 9: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY OTHER MODALITIES, 2019-2028 (IN $ MILLION)

FIGURE 10: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY APPLICATION, IN 2019

FIGURE 11: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY RESPIRATORY, 2019-2028 (IN $ MILLION)

FIGURE 12: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY CARDIAC, 2019-2028 (IN $ MILLION)

FIGURE 13: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR), 2019-2028 (IN $ MILLION)

FIGURE 14: ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 15: CHINA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 16: JAPAN EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 17: INDIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 18: AUSTRALIA & NEW ZEALAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 19: SOUTH KOREA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 20: THAILAND EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 21: INDONESIA EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 22: VIETNAM EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

FIGURE 23: REST OF ASIA PACIFIC EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET, 2019-2028 (IN $ MILLION)

Segmentation

GEOGRAPHICAL ANALYSIS
- ASIA PACIFIC
  - CHINA
  - JAPAN
  - INDIA
  - AUSTRALIA & NEW ZEALAND
  - SOUTH KOREA
  - THAILAND
  - INDONESIA
  - VIETNAM
  - REST OF ASIA PACIFIC

MARKET BY MODALITY
- VENO-VENOUS
- VENO-ARTERIAL
- OTHER MODALITIES
MARKET BY APPLICATION
- RESPIRATORY
- CARDIAC
- EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)

Request Free Sample

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.